Contineum Therapeutics, Inc.
Contineum Therapeutics, Inc. (CTNM) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 7 transactions totaling $94.5K, demonstrating a bearish sentiment with -$94.5K in net insider flow. The most recent transaction on Dec 29, 2025 involved a transaction of 3,611 shares valued at $16.2K.
CTNM Insider Activity Summary
Who Is Buying CTNM Stock?
No significant insider buying has been recorded for CTNM in the recent period.
Who Is Selling CTNM Stock?
No significant insider selling has been recorded for CTNM in the recent period.
Is Contineum Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CTNM is bearish with an Insider Alignment Score of 0/100 and a net flow of -$94.5K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
CTNM Frequently Asked Questions
Understanding CTNM Insider Activity
Insider trading at Contineum Therapeutics, Inc. (CTNM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading CTNM stock, having executed 7 transactions in the past 90 days. The most active insider is Tim Watkins (Executive), who has made 2 transactions totaling $59.8K.
Related Tools
Track Contineum Therapeutics, Inc. Insider Activity
Get notified when executives and directors at CTNM file new Form 4 transactions